Market Engagement - Consultant-led Clinical Review Service for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (ME/CFS)

This is an advertisement for market testing only to gauge market interest which will influence future commissioning and procurement direction. This advertisement is issued under the Provider Selection Regime (PSR) of the Healthcare Services Regulations 2023. NHS Shropshire Telford and Wrekin Integrated Care Board ICB (STW ICB) has not decided at this point which PSR process best applies. NHS Shropshire Telford and Wrekin Integrated Care Board (STW ICB) has a requirement for a Consultant-led Clinical Review Service for existing patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (ME/CFS). STW ICB are seeking Expressions of Interest (EoIs) from potential providers that are suitably qualified and experienced in delivering ME/CFS Consultant-led Clinical Review Services. Any Provider wishing to express an interest in delivering the consultant led ME/CFS clinical review service in the Shropshire, Telford and Wrekin (STW) area should register their interest and complete the questionnaire on the Atamis Health Family eCommercial System at https://health-family.force.com/s/Welcome, Atamis reference C415143, no later than 16:00 hours on 23/02/2026.